Sen. Baucus Says Industry Is "Divided" Over Proposed Device Tax
This article was originally published in The Gray Sheet
Executive Summary
Sen. Max Baucus, D-Mont., suggested last week that a "fair" compromise on the amount device companies should contribute to health care reform is close at hand, but he expressed frustration that industry is not speaking with a single voice
You may also be interested in...
Conference Collaboration Sign Of Growing AdvaMed, MDMA Partnership
While the two US-based medical device lobby groups, AdvaMed and MDMA, may have butted heads in the past, they are showing an increasing level of cooperation, most recently with plans to partner on the upcoming Medtech Conference in San Jose.
St. Jude's Departure From AdvaMed Highlights Inherent Industry Tensions
St. Jude Medical CEO Daniel Starks has resigned from AdvaMed's board of directors and the company has left the organization, citing "strong dissent" over how to respond to proposed medical device fees in pending health reform legislation
St. Jude's Departure From AdvaMed Highlights Inherent Industry Tensions
St. Jude Medical CEO Daniel Starks has resigned from AdvaMed's board of directors and the company has left the organization, citing "strong dissent" over how to respond to proposed medical device fees in pending health reform legislation